COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Option

Purpose of Study

To determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation following percutaneous catheter ablation for non-valvular atrial fibrillation

Trial Status

Enrolling

Eligibility Criteria

Underwent a prior catheter ablation for non-valvular AF or planning to have a clinically indicated catheter ablation

Duration of Participation

Approximately 3 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: jyoung@iowaheart.com